<DOC>
	<DOCNO>NCT00948103</DOCNO>
	<brief_summary>Second line treatment detrusor hyperreflexia intravesical BTX-A injection . First 300 unit Botox dilute 30 ml preservative-free saline . Using rigid cystoscope injection needle , BTX-A inject 30 site within detrusor muscle . The used KALINOX® ( 50 % nitrous oxide oxygen ) inhalation demonstrate analgesic efficacy various procedure ( obstetric , liver biopsy , transrectal ultrasound guide prostate biopsy , emergency ) The aim study investigate safety efficacy analgesia N2O/O2 inhalation detrusor BTX-A injection use rigid cystoscope .</brief_summary>
	<brief_title>The Interest Nitrous Oxide During Intravesical Injection Botulinum Toxin A</brief_title>
	<detailed_description>First line treatment detrusor hyperreflexia use antimuscarinic medication . However , medication unwanted side effect often good enough decrease incontinence case severe neurogenic detrusor overactivity . Some invasive surgical procedure possible sacral nerve stimulator , sacral rhizotomy , bladder myomectomy bladder augmentation . But still treatment option medical complication . Recently , data show clinical application botulinum neurotoxin A ( BTX-A ) detrusor muscle case resistant neurogenic detrusor overactivity conventional treatment anticholinergic medication . In study author perform intravesical BTX-A injection . First 300 unit Botox dilute 30 ml preservative-free saline . Using rigid cystoscope injection needle , BTX-A inject 30 site within detrusor muscle . To reduce pain , instillation lidocaine botulinum-A toxin injection use bladder . On 10-point rating scale mean pain score patient underwent injection Botox conventional lidocaine instillation 4.0 ( SD 1.6 ) . The used KALINOX® ( 50 % nitrous oxide oxygen ) inhalation demonstrate analgesic efficacy various procedure ( obstetric , liver biopsy , transrectal ultrasound guide prostate biopsy , emergency… ) associate mild moderate pain technically simple use . Early study indicate 30 % nitrous oxide equipotent 10 15 mg. morphine . Except patient severe chronic obstructive pulmonary disease KALINOX® inhalation safe acceptable method sedation analgesia . It nonirritant excrete unchanged lung . The aim study investigate safety efficacy analgesia N2O/O2 inhalation detrusor BTX-A injection use rigid cystoscope . Will include patient severe neurogenic detrusor overactivity preserve bladder sensibility treat botulinum-A toxin injection detrusor muscle Patients randomize group receive KALINOX® via breath activate device control group receive oxygen similar breathing device . The investigator involved randomization process since gas cylinder cover blind gas use . All patient involve blind gas inhale . The patient score injection pain anxiety 10-point rating scale . Furthermore duration practice measure . The hypothesis analgesia KALINOX® show significant difference pain perception among 2 group .</detailed_description>
	<mesh_term>Nitrous Oxide</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Man woman 18 year Patient overactive bladder First intravesical Botulinum injection Bladder sensitivity urodynamic Patient present contraindication injection Cystoscopy realize injection botulinal toxin A Negative pregnancy test woman childbearing age Signing inform consent form , appropriate information provide Pregnancy Contraindication toxin severe myasthenia , syndrome EatonLambert , amyotrophic lateral sclerosis Treatment antibiotic aminoglycoside Allergies know toxin , anesthetic use study Patients anticoagulant , take treatment antiaggregant platelet 10 day precede injection Haemophilia deficit factor coagulation responsible disorder haemostasis Current urinary infection define ECBU superior bacteriuria 10°5 / ml leucocyturia superior 10°4 / ml Current genital infection four week precede injection Histories irradiation pelvic treatment course neoplasia Current treatment six month precede randomisation pharmacological ENDOVESICAL agent Patients require ventilation pure oxygen Intracranial high blood pressure Conscience alteration Lung diseases Bubbles emphysema Gaseous embolism Accident dive Abdominal gaseous distension Patient receive recently ophthalmic gas ( SF6 , C3F8 , C2F6 ) use eye surgery long persist bubble gas inside eye least period 3 month Facial traumatism Chronic respiratory failure Analgesic treatment morphine morphine agonists class 3 Psychiatric pathology interfere compliance protocol allow correct evaluation result Patient participate clinical study 3 month precede inclusion No affiliation social insurance system</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Nitrous Oxide</keyword>
	<keyword>Administration , Intravesical Drug</keyword>
	<keyword>Botulinum toxin</keyword>
</DOC>